Yutaka Kawakami
#132,580
Most Influential Person Now
Researcher
Yutaka Kawakami's AcademicInfluence.com Rankings
Yutaka Kawakamicomputer-science Degrees
Computer Science
#5901
World Rank
#6225
Historical Rank
Computational Linguistics
#918
World Rank
#932
Historical Rank
Machine Learning
#1741
World Rank
#1764
Historical Rank
Artificial Intelligence
#1985
World Rank
#2019
Historical Rank
Download Badge
Computer Science
Yutaka Kawakami's Degrees
- PhD Computer Science University of Tokyo
- Masters Computer Science University of Tokyo
- Bachelors Computer Science University of Tokyo
Similar Degrees You Can Earn
Why Is Yutaka Kawakami Influential?
(Suggest an Edit or Addition)Yutaka Kawakami's Published Works
Number of citations in a given year to any of this author's works
Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author
Published Works
- Immunologic and therapeutic evaluation of a synthetic peptide vaccine for the treatment of patients with metastatic melanoma (1998) (1897)
- International validation of the consensus Immunoscore for the classification of colon cancer: a prognostic and accuracy study (2018) (1224)
- Towards the introduction of the ‘Immunoscore’ in the classification of malignant tumours (2013) (1136)
- Cloning of the gene coding for a shared human melanoma antigen recognized by autologous T cells infiltrating into tumor. (1994) (1121)
- Identification of a human melanoma antigen recognized by tumor-infiltrating lymphocytes associated with in vivo tumor rejection. (1994) (964)
- Identification of the immunodominant peptides of the MART-1 human melanoma antigen recognized by the majority of HLA-A2-restricted tumor infiltrating lymphocytes (1994) (899)
- Cancer metastasis is accelerated through immunosuppression during Snail-induced EMT of cancer cells. (2009) (739)
- Cancer classification using the Immunoscore: a worldwide task force (2012) (719)
- Identification of human cancers deficient in antigen processing (1993) (657)
- Recognition of multiple epitopes in the human melanoma antigen gp100 by tumor-infiltrating T lymphocytes associated with in vivo tumor regression. (1995) (621)
- Improved induction of melanoma-reactive CTL with peptides from the melanoma antigen gp100 modified at HLA-A*0201-binding residues. (1996) (610)
- The BRAF–MAPK signaling pathway is essential for cancer-immune evasion in human melanoma cells (2006) (607)
- A defined commensal consortium elicits CD8 T cells and anti-cancer immunity (2019) (576)
- Melanocyte lineage-specific antigen gp100 is recognized by melanoma- derived tumor-infiltrating lymphocytes (1994) (571)
- A mutated beta-catenin gene encodes a melanoma-specific antigen recognized by tumor infiltrating lymphocytes (1996) (565)
- Loss of functional beta 2-microglobulin in metastatic melanomas from five patients receiving immunotherapy. (1996) (516)
- RNA helicase encoded by melanoma differentiation-associated gene 5 is a major autoantigen in patients with clinically amyopathic dermatomyositis: Association with rapidly progressive interstitial lung disease. (2009) (493)
- Induction of tumor-reactive CTL from peripheral blood and tumor-infiltrating lymphocytes of melanoma patients by in vitro stimulation with an immunodominant peptide of the human melanoma antigen MART-1. (1995) (325)
- Human circulating CD14+ monocytes as a source of progenitors that exhibit mesenchymal cell differentiation (2003) (319)
- Human CD4+ T cells specifically recognize a shared melanoma-associated antigen encoded by the tyrosinase gene. (1994) (297)
- Utilization of an alternative open reading frame of a normal gene in generating a novel human cancer antigen (1996) (280)
- Defective vasculogenesis in systemic sclerosis (2004) (275)
- Recognition of tyrosinase by tumor-infiltrating lymphocytes from a patient responding to immunotherapy. (1994) (263)
- Human tumor antigens recognized by T cells. (1996) (262)
- Molecular characterization of defective antigen processing in human prostate cancer. (1995) (239)
- Identification of a gene encoding a melanoma tumor antigen recognized by HLA-A31-restricted tumor-infiltrating lymphocytes [published erratum appears in J Exp Med 1995 Mar 1;181(3):1261] (1995) (225)
- Identification of TRP-2 as a Human Tumor Antigen Recognized by Cytotoxic T Lymphocytes (1996) (220)
- Identification of subdominant CTL epitopes of the GP100 melanoma-associated tumor antigen by primary in vitro immunization with peptide-pulsed dendritic cells. (1997) (209)
- Identification of a shared HLA-A*0201-restricted T-cell epitope from the melanoma antigen tyrosinase-related protein 2 (TRP2). (1998) (202)
- Inhibition of growth and invasive ability of melanoma by inactivation of mutated BRAF with lentivirus-mediated RNA interference (2004) (192)
- Antigen-specific tumor vaccines. Development and characterization of recombinant adenoviruses encoding MART1 or gp100 for cancer therapy. (1996) (183)
- Quantitative correlation between HLA class I allele expression and recognition of melanoma cells by antigen-specific cytotoxic T lymphocytes. (1995) (183)
- Identification of a tyrosinase epitope recognized by HLA-A24-restricted, tumor-infiltrating lymphocytes. (1995) (176)
- Interleukin 4 promotes the growth of tumor-infiltrating lymphocytes cytotoxic for human autologous melanoma (1988) (168)
- Expression of the neural RNA‐binding protein Musashi1 in human gliomas (2001) (166)
- Shared human melanoma antigens. Recognition by tumor-infiltrating lymphocytes in HLA-A2.1-transfected melanomas. (1992) (166)
- Optimization of an siRNA‐expression system with an improved hairpin and its significant suppressive effects in mammalian cells (2004) (165)
- Cloning of a new gene encoding an antigen recognized by melanoma-specific HLA-A24-restricted tumor-infiltrating lymphocytes. (1995) (160)
- Induction of antigen‐specific human CD4+ T cell anergy by peripheral blood DC2 precursors (2001) (160)
- Pivotal Roles of T-Helper 17-Related Cytokines, IL-17, IL-22, and IL-23, in Inflammatory Diseases (2013) (153)
- Defining the critical hurdles in cancer immunotherapy (2011) (152)
- Recognition of multiple epitopes in the human melanoma antigen gp100 by peripheral blood lymphocytes stimulated in vitro with synthetic peptides. (1995) (145)
- Spleen Is a Primary Site for Activation of Platelet-Reactive T and B Cells in Patients with Immune Thrombocytopenic Purpura1 (2002) (145)
- Analysis of expression of the melanoma-associated antigens MART-1 and gp100 in metastatic melanoma cell lines and in in situ lesions. (1996) (142)
- Identification of a novel peptide derived from the melanocyte‐specific gp100 antigen as the dominant epitope recognized by an HLA‐A2.1‐restricted anti‐melanoma CTL line (1995) (142)
- A significant role of stromal fibroblasts in rapidly progressive dry eye in patients with chronic GVHD. (2001) (141)
- Human tumor antigens recognized by T-cells (1997) (140)
- Molecular mechanisms used by tumors to escape immune recognition: immunogenetherapy and the cell biology of major histocompatibility complex class I. (1993) (136)
- Helicobacter pylori eradication shifts monocyte Fcgamma receptor balance toward inhibitory FcgammaRIIB in immune thrombocytopenic purpura patients. (2008) (135)
- Immunodominant epitopes on glycoprotein IIb-IIIa recognized by autoreactive T cells in patients with immune thrombocytopenic purpura. (2001) (132)
- The intronic region of an incompletely spliced gp100 gene transcript encodes an epitope recognized by melanoma-reactive tumor-infiltrating lymphocytes. (1997) (127)
- Recognition of shared melanoma antigens in association with major HLA-A alleles by tumor infiltrating T lymphocytes from 123 patients with melanoma. (2000) (126)
- Endothelial Differentiation Potential of Human Monocyte‐Derived Multipotential Cells (2006) (124)
- Identification of new melanoma epitopes on melanosomal proteins recognized by tumor infiltrating T lymphocytes restricted by HLA-A1, -A2, and -A3 alleles. (1998) (122)
- CCL2 is critical for immunosuppression to promote cancer metastasis (2013) (121)
- Longitudinal analysis of autoantibody response to topoisomerase I in systemic sclerosis. (2000) (119)
- Tumor-specific immunological recognition of frameshift-mutated peptides in colon cancer with microsatellite instability. (2003) (114)
- Prognostic value of tumor-infiltrating lymphocytes differs depending on histological type and smoking habit in completely resected non-small-cell lung cancer. (2016) (112)
- Immunobiology of human melanoma antigens MART-1 and gp100 and their use for immuno-gene therapy. (1997) (112)
- The mechanisms of cancer immunoescape and development of overcoming strategies (2011) (109)
- Periductal area as the primary site for T-cell activation in lacrimal gland chronic graft-versus-host disease. (2003) (109)
- IL-4 regulates IL-2 induction of lymphokine-activated killer activity from human lymphocytes. (1989) (108)
- Recommendations from the iSBTc-SITC/FDA/NCI Workshop on Immunotherapy Biomarkers (2011) (108)
- Generation of Human Melanocytes from Induced Pluripotent Stem Cells (2011) (105)
- Production of recombinant MART-1 proteins and specific antiMART-1 polyclonal and monoclonal antibodies: use in the characterization of the human melanoma antigen MART-1. (1997) (105)
- A role of autoantibody‐mediated platelet destruction in thrombocytopenia in patients with cirrhosis (2003) (104)
- Binding of beta 2-glycoprotein I to anionic phospholipids facilitates processing and presentation of a cryptic epitope that activates pathogenic autoreactive T cells. (2005) (103)
- Characterization of the functional specificity of a cloned T-cell receptor heterodimer recognizing the MART-1 melanoma antigen. (1995) (103)
- Generation of tumor-specific CTLs from melanoma patients by using peripheral blood stimulated with allogeneic melanoma tumor cell lines. Fine specificity and MART-1 melanoma antigen recognition. (1995) (98)
- The use of melanosomal proteins in the immunotherapy of melanoma. (1998) (97)
- Immune Suppression and Resistance Mediated by Constitutive Activation of Wnt/β-Catenin Signaling in Human Melanoma Cells (2012) (97)
- Marijuana components suppress induction and cytolytic function of murine cytotoxic T cells in vitro and in vivo. (1991) (96)
- Downregulation of KIF23 suppresses glioma proliferation (2012) (90)
- Melanoma Cells Control Antimelanoma CTL Responses via Interaction between TIGIT and CD155 in the Effector Phase. (2016) (87)
- Identification of the genes encoding cancer antigens: implications for cancer immunotherapy. (1996) (85)
- Increase in circulating endothelial precursors by atorvastatin in patients with systemic sclerosis. (2006) (85)
- Identification of MART-1-specific T-cell receptors: T cells utilizing distinct T-cell receptor variable and joining regions recognize the same tumor epitope. (1994) (81)
- Validation of the Immunoscore (IM) as a prognostic marker in stage I/II/III colon cancer: Results of a worldwide consortium-based analysis of 1,336 patients. (2016) (80)
- Autoreactive CD4(+) T-cell clones to beta2-glycoprotein I in patients with antiphospholipid syndrome: preferential recognition of the major phospholipid-binding site. (2001) (80)
- Enhanced Cancer Immunotherapy Using STAT3-Depleted Dendritic Cells with High Th1-Inducing Ability and Resistance to Cancer Cell-Derived Inhibitory Factors (2011) (80)
- Quantitative monitoring of the PRAME gene for the detection of minimal residual disease in leukaemia (2001) (79)
- Multicenter International Society for Immunotherapy of Cancer Study of the Consensus Immunoscore for the Prediction of Survival and Response to Chemotherapy in Stage III Colon Cancer. (2020) (79)
- T cells that are autoreactive to beta2-glycoprotein I in patients with antiphospholipid syndrome and healthy individuals. (2000) (78)
- Identification of human tumor antigens and its implications for diagnosis and treatment of cancer (2004) (77)
- Involvement of overexpressed wild-type BRAF in the growth of malignant melanoma cell lines (2004) (74)
- Increase of oligodendrocyte progenitor cells after spinal cord injury (2001) (74)
- Enhancement of Immunologic Tumor Regression by Intratumoral Administration of Dendritic Cells in Combination with Cryoablative Tumor Pretreatment and Bacillus Calmette-Guerin Cell Wall Skeleton Stimulation (2006) (74)
- Autoantibody to c-Mpl (thrombopoietin receptor) in systemic lupus erythematosus: relationship to thrombocytopenia with megakaryocytic hypoplasia. (2002) (73)
- Isolation of cancer stem-like cells from a side population of a human glioblastoma cell line, SK-MG-1. (2010) (73)
- Prolonged thrombocytopenia after allogeneic hematopoietic stem cell transplantation: associations with impaired platelet production and increased platelet turnover (2006) (72)
- Identification of a human glioma antigen, SOX6, recognized by patients' sera (2004) (72)
- Nuclear targeted suppression of NF-kappa B activity by the novel quinone derivative E3330. (1998) (72)
- Autoreactive CD8+ cytotoxic T lymphocytes to major histocompatibility complex class I chain-related gene A in patients with Behçet's disease. (2004) (72)
- Functional analysis of HOXD9 in human gliomas and glioma cancer stem cells (2011) (71)
- T-cell receptor usage by melanoma-specific clonal and highly oligoclonal tumor-infiltrating lymphocyte lines. (1994) (71)
- Macrophage migration inhibitory factor (MIF) promotes cell survival and proliferation of neural stem/progenitor cells (2012) (70)
- Evaluation of platelet kinetics in patients with liver cirrhosis: Similarity to idiopathic thrombocytopenic purpura (2007) (70)
- Results of a phase I clinical study using autologous tumour lysate-pulsed monocyte-derived mature dendritic cell vaccinations for stage IV malignant melanoma patients combined with low dose interleukin-2 (2003) (70)
- Novel autoantibodies to a voltage-gated potassium channel KV1.4 in a severe form of myasthenia gravis (2005) (69)
- Effective inhibition of cell growth and invasion of melanoma by combined suppression of BRAF (V599E) and Skp2 with lentiviral RNAi (2006) (67)
- Differential Expression of MART‐1 in Primary and Metastatic Melanoma Lesions (1997) (66)
- Lack of evidence for an increased microchimerism in the circulation of patients with Sjögren's syndrome (2001) (66)
- A Mutated f3-Catenin Gene Encodes a Melanoma-specifi c Antigen Recognized by Tumor Infiltrating Lymphocytes By Paul F. tLobbins,* Mona E1-Gamil,* Yong F. Li,* (1996) (65)
- A phase ΙI study of five peptides combination with oxaliplatin-based chemotherapy as a first-line therapy for advanced colorectal cancer (FXV study) (2014) (65)
- Intratumoural-infiltrating CD4 + and FOXP3 + T cells as strong positive predictive markers for the prognosis of resectable colorectal cancer (2019) (65)
- Autocrine and paracrine loops between cancer cells and macrophages promote lymph node metastasis via CCR4/CCL22 in head and neck squamous cell carcinoma (2013) (64)
- Targeting FSTL1 prevents tumor bone metastasis and consequent immune dysfunction. (2013) (64)
- Coxsackievirus-adenovirus receptor genetically fused to anti-human CD40 scFv enhances adenoviral transduction of dendritic cells (2002) (64)
- Suppression of myeloid cell leukemia-1 (Mcl-1) enhances chemotherapy-associated apoptosis in gastric cancer cells (2012) (62)
- T-cell recognition of self peptides as tumor rejection antigens (1996) (62)
- T-cell recognition of human melanoma antigens. (1993) (61)
- Phase I pilot study of Wilms tumor gene 1 peptide-pulsed dendritic cell vaccination combined with gemcitabine in pancreatic cancer (2015) (61)
- Genetic reversion in an acute myelogenous leukemia cell line from a Fanconi anemia patient with biallelic mutations in BRCA2. (2003) (60)
- Implantation of dendritic cells in injured adult spinal cord results in activation of endogenous neural stem/progenitor cells leading to de novo neurogenesis and functional recovery (2004) (60)
- Differential expression of MAGE-1, -2, and -3 messenger RNA in transformed and normal human cell lines. (1993) (59)
- A new melanoma antigen fatty acid-binding protein 7, involved in proliferation and invasion, is a potential target for immunotherapy and molecular target therapy. (2006) (59)
- Prognostic Significance of Interleukin-8 and CD163-Positive Cell-Infiltration in Tumor Tissues in Patients with Oral Squamous Cell Carcinoma (2014) (58)
- AMP kinase-related kinase NUAK2 affects tumor growth, migration, and clinical outcome of human melanoma (2011) (57)
- Effects of a Helicobacter pylori eradication regimen on anti-platelet autoantibody response in infected and uninfected patients with idiopathic thrombocytopenic purpura. (2006) (57)
- Preferential expression and frequent IgG responses of a tumor antigen, SOX5, in glioma patients (2007) (57)
- Bone Marrow Lacks a Transplantable Progenitor for Smooth Muscle Type α‐Actin–Expressing Cells (2006) (56)
- Cardiomyogenic potential of mesenchymal progenitors derived from human circulating CD14+ monocytes. (2005) (56)
- Single nucleotide polymorphisms of the inflammatory cytokine genes in adults with chronic immune thrombocytopenic purpura (2004) (55)
- Epithelial mesenchymal transition in human ocular chronic graft-versus-host disease. (2009) (55)
- A simple and reliable behavioral analysis of locomotor function after spinal cord injury in mice. Technical note. (2002) (55)
- Carbonic Anhydrase II Is a Tumor Vessel Endothelium–Associated Antigen Targeted by Dendritic Cell Therapy (2005) (54)
- Determination of poor prognostic immune features of tumour microenvironment in non-smoking patients with lung adenocarcinoma. (2017) (54)
- MIF Maintains the Tumorigenic Capacity of Brain Tumor-Initiating Cells by Directly Inhibiting p53. (2016) (51)
- Genomic alterations in primary cutaneous melanomas detected by metaphase comparative genomic hybridization with laser capture or manual microdissection: 6p gains may predict poor outcome. (2005) (50)
- Functional recovery after spinal cord injury in mice through activation of microglia and dendritic cells after IL‐12 administration (2008) (50)
- Identification of an immunodominant epitope on RNA polymerase III recognized by systemic sclerosis sera: application to enzyme-linked immunosorbent assay. (2002) (49)
- Involvement of local renin‐angiotensin system in immunosuppression of tumor microenvironment (2017) (49)
- Suppression of autoreactive T-cell response to glycoprotein IIb/IIIa by blockade of CD40/CD154 interaction: implications for treatment of immune thrombocytopenic purpura. (2003) (48)
- Differences in autoantibody response to Th/To between systemic sclerosis and other autoimmune diseases (2002) (48)
- Bone marrow lacks a transplantable progenitor for smooth muscle type alpha-actin-expressing cells. (2006) (48)
- In situ cancer vaccination with a replication-conditional HSV for the treatment of liver metastasis of colon cancer (2002) (48)
- Cancer-induced heterogeneous immunosuppressive tumor microenvironments and their personalized modulation. (2016) (47)
- Neurogenic potential of progenitors derived from human circulating CD14+ monocytes (2006) (47)
- Angiotensin II Type 1 Receptor Antagonist Attenuates Lacrimal Gland, Lung, and Liver Fibrosis in a Murine Model of Chronic Graft-Versus-Host Disease (2013) (47)
- Identification of HLA‐A2‐ and A24‐restricted T‐cell epitopes derived from SOX6 expressed in glioma stem cells for immunotherapy (2009) (46)
- T cell immune responses against melanoma and melanocytes in cancer and autoimmunity. (2000) (46)
- Emerging concepts in biomarker discovery; The US-Japan workshop on immunological molecular markers in oncology (2009) (46)
- A Novel Cancer Testis Antigen That Is Frequently Expressed in Pancreatic, Lung, and Endometrial Cancers (2006) (46)
- Novel System Evaluating In Vivo Pathogenicity of Desmoglein 3-Reactive T Cell Clones Using Murine Pemphigus Vulgaris1 (2008) (46)
- Evaluation of cytomegalovirus‐specific T‐cell reconstitution in patients after various allogeneic haematopoietic stem cell transplantation using interferon‐γ‐enzyme‐linked immunospot and human leucocyte antigen tetramer assays with an immunodominant T‐cell epitope (2005) (46)
- Preferentially Expressed Antigen of Melanoma (PRAME) in the Development of Diagnostic and Therapeutic Methods for Hematological Malignancies (2003) (45)
- T‐Cell Receptor Repertoire in Tumor‐Infiltrating Lymphocytes. Analysis of Melanoma‐Specific Long‐Term Lines (1994) (45)
- Aberrant Myosin 1b Expression Promotes Cell Migration and Lymph Node Metastasis of HNSCC (2014) (45)
- Donor fibroblast chimerism in the pathogenic fibrotic lesion of human chronic graft-versus-host disease. (2005) (44)
- Predominant Development of Mature and Functional Human NK Cells in a Novel Human IL-2–Producing Transgenic NOG Mouse (2015) (43)
- Restricted T-cell receptor beta-chain usage by T cells autoreactive to beta(2)-glycoprotein I in patients with antiphospholipid syndrome. (2002) (42)
- T helper type 2-biased natural killer cell phenotype in patients with pemphigus vulgaris. (2007) (42)
- Induction of immunoregulatory CD271+ cells by metastatic tumor cells that express human endogenous retrovirus H. (2014) (42)
- Simultaneous suppression of MITF and BRAFV600E enhanced inhibition of melanoma cell proliferation (2009) (42)
- Human melanoma antigens recognized by T lymphocytes. (1996) (42)
- Immuno-viral therapy of brain tumors by combination of viral therapy with cancer vaccination using a replication-conditional HSV (2002) (42)
- Functional analysis of KIF20A, a potential immunotherapeutic target for glioma (2017) (41)
- Melanoma Cells Control Anti-Melanoma CTL Responses via Interaction between TIGIT and CD155 in the Effector Phase. (2015) (40)
- Human PBMC-transferred murine MHC class I/II-deficient NOG mice enable long-term evaluation of human immune responses (2017) (39)
- Activation of dendritic-like cells and neural stem/progenitor cells in injured spinal cord by GM-CSF (2009) (39)
- Detection of shared MHC-restricted human melanoma antigens after vaccinia virus-mediated transduction of genes coding for HLA. (1993) (38)
- HLA class II alleles in Japanese patients with immune thrombocytopenic purpura. Associations with anti-platelet glycoprotein autoantibodies and responses to splenectomy. (2000) (38)
- Autoantibody to CD40 ligand in systemic lupus erythematosus: association with thrombocytopenia but not thromboembolism. (2006) (37)
- Transplantation of side population cells restores the function of damaged exocrine glands through clusterin (2012) (37)
- Lentiviral vector-mediated RNAi and its use for cancer research. (2007) (37)
- Expression of a transcriptional factor, SOX6, in human gliomas (2004) (37)
- Long-term maintenance of peripheral blood derived human NK cells in a novel human IL-15- transgenic NOG mouse (2017) (36)
- Generation of Human Immunosuppressive Myeloid Cell Populations in Human Interleukin-6 Transgenic NOG Mice (2018) (35)
- Targeted inhibition of IL‐10‐secreting CD25− Treg via p38 MAPK suppression in cancer immunotherapy (2010) (35)
- Tumor antigens isolated from a patient with vitiligo and T-cell-infiltrated melanoma. (2001) (34)
- Role of heat shock protein 47, a collagen-binding chaperone, in lacrimal gland pathology in patients with cGVHD. (2007) (34)
- Aberrant fatty acid-binding protein-7 gene expression in cutaneous malignant melanoma. (2010) (34)
- Identification of a Gene Encoding a Melanoma Tumor Antigen Recognized by HLA-A31-restricted Tumor-infiltrating Lymphocytes (2003) (34)
- Autoantibodies to the Amino-Terminal Fragment of β-Fodrin Expressed in Glandular Epithelial Cells in Patients with Sjögren’s Syndrome1 (2001) (33)
- Fibroblast Growth Factor-2 Is an Important Factor that Maintains Cellular Immaturity and Contributes to Aggressiveness of Osteosarcoma (2012) (33)
- Prevention and reversal of delta-9-tetrahydrocannabinol induced depression of natural killer cell activity by interleukin-2. (1989) (33)
- Frequent Immune Responses to a Cancer/Testis Antigen, CAGE, in Patients with Microsatellite instability–Positive Endometrial Cancer (2005) (33)
- Ineffective erythropoiesis in the spleen of a patient with pyruvate kinase deficiency (2003) (33)
- Systematic Identification of Human Melanoma Antigens Using Serial Analysis of Gene Expression (SAGE) (2005) (32)
- Identification of an epigenetically silenced gene, RFX1, in human glioma cells using restriction landmark genomic scanning (2004) (32)
- Cancer‐testis antigen BORIS is a novel prognostic marker for patients with esophageal cancer (2012) (32)
- Suppression by Cannabinoids of a Cloned Cell Line with Natural Killer Cell Activity (1988) (30)
- Immune responses to DNA mismatch repair enzymes hMSH2 and hPMS1 in patients with pancreatic cancer, dermatomyositis and polymyositis (2005) (30)
- Impairment of Plasmacytoid Dendritic Cells for IFN Production by the Ligand for Immunoglobulin-Like Transcript 7 Expressed on Human Cancer Cells (2009) (30)
- Melanocyte Lineage-specific Antigen gpl00 Is Recognized by Melanoma-derived Tumor-infiltrating Lymphocytes By Alexander B. H. Bakker, Marco W. J. Schreurs, (1994) (30)
- Improvement of Cancer Immunotherapy by Combining Molecular Targeted Therapy (2013) (30)
- Phase I clinical trial of the vaccination for the patients with metastatic melanoma using gp100-derived epitope peptide restricted to HLA-A*2402 (2010) (30)
- Immune-resistant mechanisms in cancer immunotherapy (2020) (29)
- Enhanced anti‐tumor effects of the PD‐1 blockade combined with a highly absorptive form of curcumin targeting STAT3 (2020) (28)
- CHD7 promotes proliferation of neural stem cells mediated by MIF (2016) (27)
- MHC-compatible bone marrow stromal/stem cells trigger fibrosis by activating host T cells in a scleroderma mouse model (2016) (26)
- Current status of immunotherapy against gastrointestinal cancers and its biomarkers: Perspective for precision immunotherapy (2018) (26)
- Accumulation of Secretory Vesicles in the Lacrimal Gland Epithelia Is Related to Non-Sjögren's Type Dry Eye in Visual Display Terminal Users (2012) (26)
- Identification of a glioma antigen, GARC‐1, using cytotoxic T lymphocytes induced by HSV cancer vaccine (2006) (26)
- GPC1 specific CAR-T cells eradicate established solid tumor without adverse effects and synergize with anti-PD-1 Ab (2020) (26)
- Involvement of hyaluronan and its receptor CD44 with choroidal neovascularization. (2009) (26)
- Clinical significance of serum p53 antibodies in patients with ulcerative colitis and its carcinogenesis (2007) (25)
- Cytokine profile in cervical mucosa of Japanese patients with cervical intraepithelial neoplasia (2014) (25)
- Frequent immune response to a melanocyte specific protein KU-MEL-1 in patients with Vogt-Koyanagi-Harada disease (2006) (25)
- Novel Treatment of Chronic Graft-Versus-Host Disease in Mice Using the ER Stress Reducer 4-Phenylbutyric Acid (2017) (25)
- Suppression by delta-9-tetrahydrocannabinol of interleukin 2-induced lymphocyte proliferation and lymphokine-activated killer cell activity. (1988) (25)
- Mechanisms of immunologic antitumor therapy: lessons from the laboratory and clinical applications. (1990) (24)
- Identification of tumor-regression antigens in melanoma. (1996) (24)
- New cancer therapy by immunomanipulation: development of immunotherapy for human melanoma as a model system. (2000) (24)
- Mucosal microvilli in dry eye patients with chronic GVHD (2012) (24)
- Induction of protective and therapeutic antitumor immunity by a DNA vaccine with a glioma antigen, SOX6 (2008) (23)
- TGF-&bgr;1 in Tumor Microenvironments Induces Immunosuppression in the Tumors and Sentinel Lymph Nodes and Promotes Tumor Progression (2014) (23)
- Novel melanoma antigen, FCRL/FREB, identified by cDNA profile comparison using DNA chip are immunogenic in multiple melanoma patients (2005) (23)
- Recognition of Shared Melanoma Antigens by Human Tumor-Infiltrating Lymphocytes (1992) (23)
- Generation of human melanocytes from induced pluripotent stem cells. (2013) (22)
- A VEGF receptor vaccine demonstrates preliminary efficacy in neurofibromatosis type 2 (2019) (22)
- Sox6 Up-Regulation by Macrophage Migration Inhibitory Factor Promotes Survival and Maintenance of Mouse Neural Stem/Progenitor Cells (2013) (22)
- Preferential activation of circulating CD8+ and γδ T cells in patients with active Behçet's disease and HLA-B51 (2008) (22)
- Predictive biomarkers for the efficacy of peptide vaccine treatment: based on the results of a phase II study on advanced pancreatic cancer (2017) (21)
- miR-196b, miR-378a and miR-486 are predictive biomarkers for the efficacy of vaccine treatment in colorectal cancer (2017) (21)
- Development of Immunotherapy for Pancreatic Cancer (2004) (21)
- Single nucleotide polymorphism of interleukin-1beta associated with Helicobacter pylori infection in immune thrombocytopenic purpura. (2009) (21)
- NUAK2 Amplification Coupled with PTEN Deficiency Promotes Melanoma Development via CDK Activation. (2015) (21)
- Immunohistochemical analysis of SOX6 expression in human brain tumors (2004) (21)
- Tumor-infiltrating lymphocytes predict survival outcomes in patients with cervical cancer treated with concurrent chemoradiotherapy. (2020) (20)
- A pilot study of human interferon beta gene therapy for patients with advanced melanoma by in vivo transduction using cationic liposomes. (2008) (20)
- HLA class II alleles in systemic sclerosis patients with anti-RNA polymerase I/III antibody: associations with subunit reactivities. (2003) (20)
- AIM2 regulates anti-tumor immunity and is a viable therapeutic target for melanoma (2021) (20)
- Tumor associated macrophages support the growth of FGF9-induced lung adenocarcinoma by multiple mechanisms. (2018) (20)
- Expression and localization of aging markers in lacrimal gland of chronic graft-versus-host disease (2013) (20)
- Prospects for personalized combination immunotherapy for solid tumors based on adoptive cell therapies and immune checkpoint blockade therapies. (2017) (19)
- Dendritic cell based personalized immunotherapy based on cancer antigen research. (2008) (19)
- Suppression of alkali burn-induced corneal neovascularization by dendritic cell vaccination targeting VEGF receptor 2. (2008) (19)
- Immunochemoradiotherapy for patients with oral squamous cell carcinoma: augmentation of OK-432-induced helper T cell 1 response by 5-FU and X-ray irradiation. (2013) (19)
- Characterization of immortalized human chondrocytes originated from osteoarthritis cartilage. (2001) (19)
- Preferential activation of circulating CD8+ and gammadelta T cells in patients with active Behçet's disease and HLA-B51. (2008) (19)
- Identification of a Novel Cancer-Testis Antigen CRT2 Frequently Expressed in Various Cancers Using Representational Differential Analysis (2007) (19)
- Predictive biomarkers for the outcome of vaccination of five therapeutic epitope peptides for colorectal cancer. (2014) (19)
- Possible involvement of allogeneic antigens recognised by donor‐derived CD4+ cytotoxic T cells in selective GVL effects after stem cell transplantation of patients with haematological malignancy (2006) (18)
- Cancer‐induced immunosuppressive cascades and their reversal by molecular‐targeted therapy (2013) (18)
- Identification of a WT1 protein‐derived peptide, WT1187, as a HLA‐A*0206‐restricted, WT1‐specific CTL epitope (2008) (18)
- Macrophage migration inhibitory factor (MIF) promotes cell survival and proliferation of neural stem/progenitor cells (2012) (18)
- Senescence‐associated secretory phenotype promotes chronic ocular graft‐vs‐host disease in mice and humans (2020) (18)
- Rapid and efficient generation of lentivirally gene-modified dendritic cells from DC progenitors with bone marrow stromal cells. (2002) (18)
- Immunoscore clinical utility to identify good prognostic colon cancer stage II patients with high-risk clinico-pathological features for whom adjuvant treatment may be avoided. (2019) (17)
- Induction of melanoma reactive T cells by stimulator cells expressing melanoma epitope-major histocompatibility complex class I fusion proteins. (1997) (17)
- Association between programmed cell death ligand-1 expression and extracranial metastasis in intracranial solitary fibrous tumor/hemangiopericytoma (2018) (16)
- Peptide-pulsed dendritic cell vaccine in combination with carboplatin and paclitaxel chemotherapy for stage IV melanoma (2017) (16)
- Prognostic impact of expression of Bcl-2 and Bax genes in circulating immune cells derived from patients with head and neck carcinoma. (2013) (16)
- Combination Cisplatin-Epirubicin-Paclitaxel Therapy for Metastatic Extramammary Paget's Disease. (2019) (16)
- Autoreactive T-cell responses to myeloperoxidase in patients with antineutrophil cytoplasmic antibody-associated vasculitis and in healthy individuals (2008) (16)
- Identification of bladder cancer antigens recognized by IgG antibodies of a patient with metastatic bladder cancer (2004) (15)
- A pilot study of peptide vaccines for VEGF receptor 1 and 2 in patients with recurrent/progressive high grade glioma (2018) (15)
- Multicenter Phase I/II Study of Nivolumab Combined with Paclitaxel Plus Ramucirumab as Second-line Treatment in Patients with Advanced Gastric Cancer (2020) (15)
- Growth inhibition and apoptosis by an active component of OK-432, a streptococcal agent, via Toll-like receptor 4 in human head and neck cancer cell lines. (2012) (15)
- Synergistic antiproliferative effect of imatinib and adriamycin in platelet-derived growth factor receptor-expressing osteosarcoma cells (2015) (15)
- Identification of a neuron-specific human gene, KIAA1110, that is a guanine nucleotide exchange factor for ARF1. (2007) (15)
- "Smart Eye Camera": An innovative technique to evaluate tear film breakup time in a murine dry eye disease model (2019) (15)
- Augmentation of Antitumor Immune Responses by Multiple Intratumoral Inoculations of Replication-Conditional HSV and Interleukin-12 (2004) (15)
- Presence and physiologic function of the renin-angiotensin system in mouse lacrimal gland. (2012) (14)
- Heterogeneous immunogenetic background in Japanese adults with myasthenia gravis (2001) (14)
- A Randomized Phase II Study Comparing Nivolumab With Carboplatin‐Pemetrexed for Patients With EGFR Mutation–Positive Nonsquamous Non–Small‐Cell Lung Cancer Who Acquire Resistance to Tyrosine Kinase Inhibitors Not Due to a Secondary T790M Mutation: Rationale and Protocol Design for the WJOG8515L Stud (2017) (14)
- Intratumoral injection of hemagglutinating virus of Japan-envelope vector yielded an antitumor effect for advanced melanoma: a phase I/IIa clinical study (2020) (13)
- The RNA silencing technology applied by lentiviral vectors in oncology. (2010) (13)
- Immunological detection of altered signaling molecules involved in melanoma development (2005) (13)
- Isolation and characterization of dendritic cells from common marmosets for preclinical cell therapy studies (2008) (13)
- Clinical significance of MART-1 and HLA-A2 expression and CD8+ T cell infiltration in melanocytic lesions in HLA-A2 phenotype patients. (2001) (13)
- Dendritic cells transduced with autoantigen FCRLA induce cytotoxic lymphocytes and vaccinate against murine B-cell lymphoma. (2007) (13)
- Ocular Surface and Tear Film Characteristics in a Sclerodermatous Chronic Graft-Versus-Host Disease Mouse Model (2018) (12)
- Lack of circulating autoantibodies to bone morphogenetic protein receptor-II or activin receptor-like kinase 1 in mixed connective tissue disease patients with pulmonary arterial hypertension. (2005) (12)
- Cascade of Inflammatory, Fibrotic Processes, and Stress-Induced Senescence in Chronic GVHD-Related Dry Eye Disease (2021) (12)
- IgG response to MHC class I epitope peptides is a quantitative predictive biomarker in the early course of treatment of colorectal cancer using therapeutic peptides. (2018) (12)
- Suppression of choroidal neovascularization by dendritic cell vaccination targeting VEGFR2. (2007) (12)
- NOD-Rag2null IL-2Rγnull Mice: An Alternative to NOG Mice for Generation of Humanized Mice (2014) (12)
- Programmed cell death ligand 1 (PD-L1) blockade attenuates metastatic colon cancer growth in cAMP-response element-binding protein (CREB)-binding protein (CBP)/β-catenin inhibitor-treated livers (2019) (12)
- 31st Annual Meeting and Associated Programs of the Society for Immunotherapy of Cancer (SITC 2016): late breaking abstracts (2016) (12)
- Recognition of neuroectodermal tumors by melanoma-specific cytotoxic T lymphocytes: evidence for antigen sharing by tumors derived from the neural crest (1994) (12)
- CXorf48 is a potential therapeutic target for achieving treatment-free remission in CML patients (2017) (11)
- Adjuvant effects of formalin‐inactivated HSV through activation of dendritic cells and inactivation of myeloid‐derived suppressor cells in cancer immunotherapy (2011) (11)
- A Pilot Study of Vaccine Therapy with Multiple Glioma Oncoantigen/Glioma Angiogenesis-Associated Antigen Peptides for Patients with Recurrent/Progressive High-Grade Glioma (2019) (11)
- Clinical and histopathological analyses of VEGF receptors peptide vaccine in patients with primary glioblastoma - a case series (2020) (11)
- Analysis of the Tumor Reactivity of Tumor-Infiltrating Lymphocytes in a Metastatic Melanoma Lesion that Lost Major Histocompatibility Complex Class I Expression after Anti-PD-1 Therapy. (2019) (11)
- Inter-patient and Intra-tumor Heterogeneity in the Sensitivity to Tumor-targeted Immunity in Colorectal Cancer. (2017) (10)
- Melanoma Tumor‐Infiltrating Lymphocytes Derived from Four Distinct Anatomic Sites Obtained from a Single Patient: Comparison of Functional Reactivity and Melanoma Antigen Recognition (1995) (10)
- Targeting ALCAM in the cryo-treated tumour microenvironment successfully induces systemic anti-tumour immunity. (2016) (10)
- Therapeutic potential of tranilast for the treatment of chronic graft-versus-host disease in mice (2018) (10)
- Lack of XAGE‐1b and NY‐ESO‐1 in metastatic lymph nodes may predict the potential survival of stage III melanoma patients (2017) (10)
- MSI status plus immunoscore to select metastatic colorectal cancer patients for immunotherapies (2018) (10)
- Serum cytokeratin 19 fragment 21‐1 and carcinoembryonic antigen combination assay as a biomarker of tumour progression and treatment response in extramammary Paget disease (2019) (10)
- Pilot study of WT1 peptide-pulsed dendritic cell vaccination with docetaxel in esophageal cancer. (2018) (10)
- Expansion of tumor-infiltrating lymphocytes from human tumors using the T-cell growth factors interleukin-2 and interleukin-4. (1993) (10)
- Immunotherapy Using T Cell Defined Tumor Antigens for Melanoma (1998) (9)
- Functional Role of Lacrimal Gland Fibroblasts in a Mouse Model of Chronic Graft-Versus-Host Disease (2018) (9)
- Transcription factor homeobox D9 is involved in the malignant phenotype of cervical cancer through direct binding to the human papillomavirus oncogene promoter. (2019) (9)
- Functional analysis of a novel glioma antigen, EFTUD1. (2014) (9)
- Progression of Human Renal Cell Carcinoma via Inhibition of RhoA-ROCK Axis by PARG112 (2017) (9)
- Enhanced anti-tumor effects of the PD-1/PD-L1 blockade by combining a highly absorptive form of NF-kB/STAT3 inhibitor curcumin (2014) (8)
- Siglec-7 is a predictive biomarker for the efficacy of cancer vaccination against metastatic colorectal cancer (2020) (8)
- Inhibition of Vascular Adhesion Protein‐1 for Treatment of Graft‐Versus‐Host Disease in Mice (2018) (8)
- Autophagy-dependent regulation of tumor metastasis by myeloid cells (2017) (8)
- Correction: Intratumoural-infiltrating CD4 + and FOXP3 + T cells as strong positive predictive markers for the prognosis of resectable colorectal cancer (2019) (8)
- 2015 Guidance on cancer immunotherapy development in early‐phase clinical studies (2015) (7)
- A Novel Protein Highly Expressed in Testis Is Overexpressed in Systemic Sclerosis Fibroblasts and Targeted by Autoantibodies 1 (2003) (7)
- Weekly docetaxel monotherapy for metastatic extramammary Paget’s disease: Retrospective single‐institute analysis (2020) (7)
- Identification of Novel HLA-A*24:02-Restricted Epitope Derived from a Homeobox Protein Expressed in Hematological Malignancies (2016) (7)
- Antihepatotoxic Principles of Aeginetia indica Herbs (1984) (7)
- Assay method for antihepatotoxic activity using complement-mediated cytotoxicity in primary cultured hepatocytes. (1987) (7)
- Reduced Expression of VAMP8 in Lacrimal Gland Affected by Chronic Graft-versus-Host Disease (2017) (6)
- Prospective observational study of the efficacy of nivolumab in Japanese patients with advanced melanoma (CREATIVE study) (2021) (6)
- MHC class I/II deficient NOG mice are useful for analysis of human T/B cell responses for human tumor immunology research (2013) (6)
- Quantitative analysis of PRAME for detection of minimal residual disease in leukemia. (2004) (6)
- Carboplatin and epirubicin combination therapy for advanced malignant epithelial skin tumors: Retrospective study of six patients (2018) (6)
- Positive Effects of Oral Antibiotic Administration in Murine Chronic Graft-Versus-Host Disease (2021) (5)
- Tumor antigens recognized by T cells and antibodies (2003) (5)
- A phase I/II study of nivolumab, paclitaxel, and ramucirumab as second-line in advanced gastric cancer. (2020) (5)
- IDENTIFICATION OF HUMAN CANCERS DEFECTIVE IN ANTIGEN PROCESSING (1993) (5)
- Autoreactive T cells to the P3A+ isoform of AChR alpha subunit in myasthenia gravis. (2003) (5)
- Autoreactive T cells to the P3A+ isoform of AChR α subunit in myasthenia gravis (2003) (5)
- Inhibition of vascular adhesion protein‐1 enhances the anti‐tumor effects of immune checkpoint inhibitors (2021) (5)
- The Inhibitor of Apoptosis Protein Livin Confers Resistance to Fas-Mediated Immune Cytotoxicity in Refractory Lymphoma (2020) (5)
- Dry eye associated with chronic graft-versus-host disease. (2002) (4)
- NUAK2 localization in normal skin and its expression in a variety of skin tumors with YAP. (2020) (4)
- Adoptive cell therapy using tumor‐infiltrating lymphocytes for melanoma refractory to immune‐checkpoint inhibitors (2021) (4)
- Antihepatotoxic Principles of Salvia plebeia Herbs (1984) (4)
- CCL2 is critical for immunosuppression to promote cancer metastasis (2012) (4)
- Splenic Macrophages Maintain the Anti-Platelet Autoimmune Response Via Uptake of Opsonized Platelets in Patients with Chronic ITP. (2005) (4)
- Evaluation of the appropriate surgical margin for pigmented basal cell carcinoma according to the risk factors for recurrence: a single‐institute retrospective study in Japan (2018) (4)
- Functional analysis of HOXD 9 in human gliomas and glioma cancer stem cells (2018) (4)
- Roles of Signaling Pathways in Cancer Cells and Immune Cells in Generation of Immunosuppressive Tumor-Associated Microenvironments (2013) (3)
- Author Correction: A VEGF receptor vaccine demonstrates preliminary efficacy in neurofibromatosis type 2 (2020) (3)
- MIF: functions in brain and glioblastoma (2017) (3)
- Identification of Human Tumor Antigens Recognized by T-Cells and Their Use for Immunotherapy (2003) (3)
- Microenvironment and Immunology Induction of Immunoregulatory CD 271 þ Cells by Metastatic Tumor Cells That Express Human Endogenous Retrovirus H (2014) (3)
- Response of nivolumab monotherapy in 124 Japanese patients with advanced melanoma: Interim analysis of prospective observational study (CREATIVE study) (2019) (3)
- [Cancer treatment by comprehensive regulation of anti-tumor immune network]. (2010) (3)
- Cluster of differentiation 30 expression in lacrimal gland and conjunctival tissues in patients with Sjögren's syndrome (2019) (3)
- [Immunotherapy targeting cancer stem cells]. (2012) (3)
- Immunoscore as a parameter predicting time to recurrence and disease-free survival in T4N0 stage II colon cancer patients. (2020) (3)
- Clinical Performance of the Consensus Immunoscore in Colon Cancer in the Asian Population from the Multicenter International SITC Study (2022) (2)
- [Recent topics on basic research for idiopathic thrombocytopenic purpura]. (2001) (2)
- Human melanoma antigens recognized by CD8+ T cells (2003) (2)
- A phase ΙI study of five peptides combination with oxaliplatin-based chemotherapy as a first-line therapy for advanced colorectal cancer (FXV study) (2014) (2)
- Significant differences in outcome between Immunoscore categories in stage I colon cancer patients. (2019) (2)
- S-1 in combination with docetaxel as salvage therapy for patients with metastatic extramammary Paget’s disease (2020) (2)
- Inflammation and pathogenic fibrosis in human ocular chronic graft versus host disease (2008) (2)
- Structure–antioxidant activity (oxygen radical absorbance capacity) relationships of phenolic compounds (2021) (2)
- Intratumoral injection of BCG-CWS-pretreated dendritic cells following tumor cryoablation. (2014) (2)
- Renin-Angiotensin System in the Tumor Microenvironment. (2020) (2)
- A Role of Macrophages in the Lacrimal Gland Inflammation of Patient With Chronic Graft versus Host Disease (2008) (2)
- Cell Clones Using Murine Pemphigus Pathogenicity of Desmoglein 3-Reactive T Novel System Evaluating In Vivo (2013) (2)
- Chemoimmunotherapy of Spontaneous Mammary Tumors in C3H/OuJ Mice by Cyclophosphamide and Interleukin‐2 (1988) (2)
- Cancer Induced Immunosuppression and Its Modulation by Signal Inhibitors (2015) (1)
- Novel elucidation and treatment of pancreatic chronic graft-versus-host disease in mice (2018) (1)
- The Potential of Using Induced Pluripotent Stem Cells in Skin Diseases (2014) (1)
- Identification of differentiation-inducing activity produced by human bone marrow stromal cell line LP101. (2004) (1)
- Identification of human melanoma antigens recognized by tumor infiltrating T lymphocytes and their use for immunotherapy (1999) (1)
- [Identification of human tumor antigens recognized by T cells]. (2005) (1)
- Introduction: Cancer Immunology Special Issue-Immunopathology. (2016) (1)
- Immunization of Mice With Dendritic Cells Primed With Epitope Peptide Derived From Vegf Receptor 2 Supresses Choroidal Neovascularization (2007) (1)
- [Development of immunotherapy for cancer: lessons from melanoma research]. (2004) (1)
- Development of Personalized Combination Cancer Immunotherapy Based on the Patients’ Immune Status (2015) (1)
- CD4 and FOXP3 as predictive markers for the recurrence of T3/T4a stage II colorectal cancer: applying a novel discrete Bayes decision rule (2022) (1)
- [Biomarkers for cancer immunotherapy]. (2012) (1)
- INCREASED EXPRESSION OF NUCLEOPHOSMIN IS ASSOCIATED WITH WORSE PATHOLOGICAL FEATURES AND PREDICTS INTRAVESICAL RECURRENCE IN PATIENTS WITH BLADDER CANCER (2008) (1)
- Combinatorial sympathetic and cytotoxic T-lymphocyte-associated protein 4 (CTLA-4) blockades inhibit the murine melanoma growth by targeting infiltrating T cells (2021) (1)
- The pharmaceutical composition for treating cancer (2015) (1)
- 1028. Virus-Mediated RNAi for Skp-2 in Human Small Cell Lung Carcinoma Cells Resulted in the Inhibition of Tumor Cell Growth through the Increase of p27Kip1 and p21 (2004) (1)
- Effect of soy isoflavones on cyclooxygenase activity. (2010) (1)
- A novel and effective oral antibiotics treatment to the graft-versus-host disease model mouse. (2019) (1)
- miR-196b and miR-486 as predictive biomarkers for the efficacy of the vaccine treatment: From the results of phase I and II studies for metastatic colorectal cancer. (2015) (1)
- Biomarkers for immunotherapy: Results from the analysis of an HLA-status double-blind, biologically randomized phase II study of five therapeutic epitope-peptides with oxaliplatin-based chemotherapy as first-line therapy for advanced colorectal cancer (FXV study). (2014) (1)
- Cancer classification using the Immunoscore: a worldwide task force (2012) (1)
- Immuno-gene therapy for cancer (2000) (1)
- Hematopoietic Stem Cells Fail to Trans-Differentiate into Smooth Muscle-Lineage Cells In Vivo. (2005) (0)
- Immunotherapy using human melanoma epitopes recognized by T cells (1998) (0)
- O-17 A TNM-Immune (TNM-I) classification staging system for predicting survival in colon cancer in a multicenter international SITC study (2020) (0)
- Author response: MHC-compatible bone marrow stromal/stem cells trigger fibrosis by activating host T cells in a scleroderma mouse model (2015) (0)
- Immune Thrombocytopenic Purpura Platelet-Reactive T and B Cells in Patients Spleen Is a Primary Site for Activation of Kawakami (2002) (0)
- A Mutated f 3-Catenin Gene Encodes a Melanoma-spec (2003) (0)
- Impaired Platelet Production and Autoantibody-Mediated Platelet Destruction Are Two Major Causes for Prolonged Thrombocytopenia after Allogeneic HSCT. (2004) (0)
- Recent progress of cancer immunology and immunotherapy. (2017) (0)
- Pathogenic Fibrosis and Inflammation of Conjunctival Chronic Graft–Versus–Host Disease (2006) (0)
- Correction to: Clinical and histopathological analyses of VEGF receptors peptide vaccine in patients with primary glioblastoma - a case series (2020) (0)
- Recent progress in identification methods for human tumor antigens recognized by T cells (2004) (0)
- Clinical and histopathological analyses of VEGF receptors peptide vaccine in patients with primary glioblastoma - a case series (2020) (0)
- CO-LOCALIZATION OF T CELLS WITH STROMAL FIBROBLASTS EXPRESSING HLA-DR AND CD54 IN THE LACRIMAL GLAND FROM PATIENTS WITH CHRONIC GRAFT-VERSUS-HOST DISEASE (cGVHD). (2000) (0)
- [Identification and characterization of pathogenic autoreactive T cells in patients with idiopathic thrombocytopenic purpura]. (2000) (0)
- T cells in patients with immune thrombocytopenic purpura Immunodominant epitopes on glycoprotein IIb-IIIa recognized by autoreactive (2013) (0)
- Long-term maintenance of peripheral blood derived human NK cells in a novel human IL-15- transgenic NOG mouse (2017) (0)
- Cancer immunotherapy with dendritic cells engineered to express tumor antigens (2000) (0)
- Correction to: Clinical and histopathological analyses of VEGF receptors peptide vaccine in patients with primary glioblastoma - a case series (2020) (0)
- Fibroblasts and Targeted by Autoantibodies Overexpressed in Systemic Sclerosis A Novel Protein Highly Expressed in Testis Is (2003) (0)
- 422. Enhancement of Human Monocyte-Derived Dendritic Cell Functions by Adenovirus- Mediated RNA Interference of STAT-3 (2006) (0)
- P45. Functional analysis of macrophage migration inhibitory factor (MIF) in the mouse neural stem/progenitor cells (2010) (0)
- Erratum: Identification of a gene encoding a melanoma tumor antigen recognized by HLA-A31-restricted tumor-infiltrating lymphocytes (Journal of Experimental Medicine (February 1995) 181 (799-804)) (1995) (0)
- Bilogical effects of various cytokines and AlGaInP diode laser irradiation on the growth of immortalized human chondrocytes (2001) (0)
- by the Novel Quinone Derivative E3330 B Activity κ Nuclear Targeted Suppression of NF (2013) (0)
- Immunoscore predicts significant differences in time to recurrence in stage I colon cancer patients (2019) (0)
- Correction: Intratumoural-infiltrating CD4 + and FOXP3 + T cells as strong positive predictive markers for the prognosis of resectable colorectal cancer (2019) (0)
- Human Cancer Biology Impairment of Plasmacytoid Dendritic Cells for IFN Production by the Ligand for Immunoglobulin-Like Transcript 7 Expressed on Human Cancer Cells (2009) (0)
- Interleukin-3 induces proliferation but not lymphokine activated killer activity from human and murine mononuclear cells. (1990) (0)
- CYFRA 21‐1 and CEA combination assay in EMPD (2019) (0)
- Supplementary material from "Novel elucidation and treatment of pancreatic chronic graft-versus-host disease in mice" (2018) (0)
- Introduction: Cancer Immunology Special Issue-Immunotherapy. (2016) (0)
- 740: Identification of Bladder Cancer Antigens Recognized by IGG Antibodies of a Patient with Metastatic Bladder Cancer (2004) (0)
- A Clinical Study Using the Hemagglutinating Virus of Japan-Envelope on Patients with Progressive Malignant Melanoma (2013) (0)
- 030 Blockade of multiple immune checkpoints cooperatively enhanced the antitumor effect of melanoma-specific CTLs (2016) (0)
- Identification of suitable immune checkpoints as targets for cancer immunotherapy (2016) (0)
- Abstract 283: Cancer MET at the metastatic lesion preserves the malignant features acquired via EMT. (2013) (0)
- The detection of fatty acid-binding protein 7 (FABP7) expression in melanoma tumors and circulating melanoma cells in blood (2006) (0)
- Human Tumor Antigens Recognized by T Cells and Their Implications for Cancer Immunotherapy (2012) (0)
- Donor–Derived Fibroblasts in the Pathogenesis of Lacrimal Gland Chronic Graft–Versus–Host Disease (2005) (0)
- 772 A BRAF inhibitor and a Toll-like receptor 7 agonist synergistically enhanced anti-tumor immune responses (2017) (0)
- Isolation of melanoma antigons recognized by T-cells and development of antigen specific immunotherapy. (2000) (0)
- INCREASED EXPRESSION OF PTPL1-ASSOCIATED RHOGAP-1(PARG1) IS ASSOCIATED WITH MALIGNANT PATHOLOGICAL FEATURES AND MAY PREDICT RECURRENCE IN PATIENTS WITH RENAL CELL CARCINOMA (RCC) (2009) (0)
- [Recent progress in experimental pituitary tumors in various animals]. (1993) (0)
- Immunobiology of the Melanoma Microenvironment (2018) (0)
- Stress-induced senescence in chronic ocular graft-versus-host disease in mice (2019) (0)
- T Lymphocytes Recognized by Autologous Tumor-Infiltrating MART-2 , Containing a Mutated Epitope Isolation of a New Melanoma Antigen (2001) (0)
- Functional analysis of MIF in human iPSCs (2016) (0)
- Immunosuppressive mechanisms induced by tumor cells during epithelial-mesenchymal transition leading to tumor metastasis (2008) (0)
- 963. MITF as a Potential Molecular Target for Gene Therapy for Human Melanoma; a Synergistic Inhibitory Effect of Inactivation of Both MITF and BRAFV600E on Melanoma Growth (2006) (0)
- Suppression by cannabinoids of the induction and function of murine cytotoxic T lymphocytes (1988) (0)
- NOVEL AUTOANTIBODY TO SALIVARY GLAND-SPECIFIC 45-kDa ANTIGEN IN PATIENTS WITH SJÖGREN'S SYNDROME (SS). (2000) (0)
- Interface of cancer stem cells and cancer immunity (2020) (0)
- 012 Activation of 4-1BB signal and co-blockade of PD-1 and TIGIT signaling synergistically enhance melanoma-specific CTL responses during the effector phase (2017) (0)
- A defined commensal consortium elicits CD8 T cells and anti-cancer immunity (2019) (0)
- Identification of human cancer antigens by SEREX (2004) (0)
- [Personalized modulation of tumor microimmune microenvironment for the development of effective combination immunotherapy]. (2018) (0)
- The significance of over-expression both of NUAK2 and of phospho-Akt (S473) on patient's survival of acral melanomas (2016) (0)
- Analysis of Pathogenic Fibrosis in an Animal Model of Ocular Chronic Graft versus Host Disease (2009) (0)
- Granulocyte-macrophage colony-stimulating factor (GM-CSF) as a remedy for nerve damage (2002) (0)
- Age-Related Changes of Gene Expression Profile in Retina of SOD1-Deficient Mice (2008) (0)
- [Cancer immunotherapy by immuno-checkpoint blockade]. (2015) (0)
- Immunosuppression through HNF-1β signaling in human ovarian clear cell cancer (2013) (0)
- IgG Response Against Melanocyte-specific Antigen in Patients With Vogt-Koyanagi-Harada Disease (2002) (0)
- Abstract 5302: Overcoming cancer immune evasion in lung carcinoma using EGFR-TKI (Gefitinib) (2010) (0)
- Cells-Catenin Signaling in Human Melanoma b Mediated by Constitutive Activation of Wnt/ Immune Suppression and Resistance (2012) (0)
- Multi-Lineage Potential of Human Monocyte-Derived Mesenchymal Progenitors (MOMPs). (2004) (0)
- Immunotherapy of Melanoma Using T-Cell-Defined Antigens (2000) (0)
- Donor Fibroblast Chimerism in Animal Model of Ocular Chronic Graft versus Host Disease (2010) (0)
- 1184 NUAK2 promote melanoma development by regulating mTOR pathway (2018) (0)
- Epithelial-Mesenchymal Transition of Conjunctival Basal Epithelia in Human Chronic Graft versus Host Disease (2008) (0)
- PAP9 Progress and future perspectives of cancer immunotherapy (2022) (0)
- Abstract 4751: Peptide vaccine induces apoptosis of antigen-specific CD8+T cells (2010) (0)
- Enhancement of anti-tumor effects of PD-1 inhibitors by modulation of lipid metabolism in tumor microenvironment (2021) (0)
- 774 Analysis of the tumor reactivity of tumor-infiltrating lymphocytes in a metastatic melanoma lesion that lost MHC class I expression after anti-PD-1 therapy (2019) (0)
- Cancer Cell-Derived Inhibitory Factors Th1-Inducing Ability and Resistance to STAT3-Depleted Dendritic Cells with High Enhanced Cancer Immunotherapy Using (2011) (0)
- The Role of the Activated MAPK Pathway through the Oncogenic BRAFV600E-Mutation in the Immune Escaping Mechanism of Melanoma (2006) (0)
- Progress of cancer immunotherapy (CS-1) Chairpersons: Nicholas Restifo, Yutaka Kawakami (2010) (0)
- CANCER-TARGETED GENE THERAPY: OTHER VIRUSES (2006) (0)
- Assay method for antihepatotoxic activity using macrophage‐mediated cytotoxicity in primary cultured hepatocytes (1987) (0)
- Co-blockade of TIGIT and PD-1 signals in tumor-infiltrating cytotoxic T lymphocytes is an effective anti-melanoma therapy (2016) (0)
- MA 05.04 Distinct Immunosuppressive Microenvironment Determines Poor Prognosis of Nonsmokers with Adenocarcinoma of Non-Small Cell Lung Cancer (2017) (0)
- Mucosal Microvilli In Dry Eye Patients With Chronic Graft-versus-host Disease (2011) (0)
- Development of new immunotherapies using melanoma antigens recognized by T cells (1998) (0)
- Predictive biomarkers for the efficacy of peptide vaccine treatment: based on the results of a phase II study on advanced pancreatic cancer (2017) (0)
- PD-1, TIGIT, and LAG-3 signals synergistically suppress the anti-melanoma CTL response in the effector phase (2017) (0)
- 539 Accelerated platelet turnover in patients with liver cirrhosis (2003) (0)
- Use of interleukin-12 for the treatment of nerve damage (2002) (0)
- [New immunotherapy for patients with neoplasms using tumor antigens recognized by T lymphocytes]. (1998) (0)
- Key points for development of immunotherapy for cancer using T cell defined tumor antigens (1999) (0)
- HLA-A 1 ,-A 2 , andA 3 Alleles Infiltrating T Lymphocytes Restricted by Melanosomal Proteins Recognized by Tumor Identification of New Melanoma Epitopes on Sakaguchi (1998) (0)
- 104P Angiogenesis-related factors and clinical outcomes in combination therapy with paclitaxel (PTX), ramucirumab (RAM) plus nivolumab (Nivo) for advanced gastric cancer (AGC) (2020) (0)
- Functional analysis of macrophage migration inhibitory factor (MIF) in the mouse neural stem/progenitor cells (2010) (0)
- Author response: GPC1 specific CAR-T cells eradicate established solid tumor without adverse effects and synergize with anti-PD-1 Ab (2020) (0)
- Personalized Cancer Immunotherapy: Immune Biomarkers and Combination Immunotherapy (2016) (0)
- Identification of tumor antigens recognized by T cells and their use for analysis of anti-tumor responses (2002) (0)
- Abstract 5403: Snail+ bone-metastatic cancer cells impair CTL induction via induction of immunoregulatory MSCs (2012) (0)
- Generation of neural crest progenitor cells from human induced pluripotent stem cells by a simple method (2011) (0)
- Serum p53 Antibodies in Patients with Ulcerative Colitis Are Associated with the Development of Colorectal Neoplasia: 805 (2005) (0)
- Frequent Immune Responses to a Cancer / Testis Antigen , CAGE , in PatientswithMicrosatellite Instability ^ Positive (2005) (0)
- Development of anti-GPC-1 (glypican-1)-CAR-T cells for adoptive T cell immunotherapies for squamous cell carcinoma (2015) (0)
- Evaluation of the platelet-specific antibody response in thrombocytopenia following allogeneic hematopoietic stem cell transplantation (2004) (0)
- Multicenter International Study of the Consensus Immunoscore for the Prediction of Relapse and Survival in Early-Stage Colon Cancer (2023) (0)
- Identification of human melanoma antigens recognized by T cells and their use for immuno-gene therapy (1997) (0)
- Analysis of antitumor immunity of HVJ-E (hemagglutinating virus of Japan envelope) and development in its clinical application for advanced malignant melanoma patients (2009) (0)
- Detection of residual disease in chronic myeloid leukemia utilizing genomic next generation sequencing reveals persistence of differentiated Ph+ B cells but not bone marrow stem/progenitors (2020) (0)
- Identification of Novel Cancer-Testis Antigen Expressed in Leukemic Stem Cells of Chronic Myelogenous Leukemia (2014) (0)
- Donor mesenchymal stem cells trigger chronic graft-versus-host disease following minor antigen-mismatched bone marrow transplantation (2012) (0)
- Cloning and expression of the gene encoding a novel colon cancer associated antigen-EID3 (2006) (0)
- Abstract 2682: New diagnostic and therapeutic target KU-MEL9 for chronic myeloid leukemia (CML) (2012) (0)
- Recent advances in cancer immunotherapy : extended abstracts for the 45th International Symposium of the Princess Takamatsu Cancer Research Fund : November 18-20, 2014 Tokyo, Japan (2015) (0)
- Interaction Between Donor Mesenchymal Stem Cells And Recipient-derived T Cells In The Pathogenesis Of Ocular Chronic Graft Versus Host Disease (2012) (0)
- A Significant Role of Mesehchymal Stem Cells in Immune Processes and Pathogenic Fibrosis In Ocular Chronic Graft Versus Host Disease (2011) (0)
- Abstract 5326: CCL2 is critical for immunoresistance in association with cancer EMT (2010) (0)
- Macrophage migration inhibitory factor (MIF) promotes proliferation and cell survival of neural stem/progenitor cells (2009) (0)
- Novel biomarkers for immunotherapy: from the results of phase I and II study of five therapeutic peptides for advanced colorectal cancer. (2016) (0)
- [Molecular targets for development of cancer immunotherapy]. (2012) (0)
- Abstract 1066: PD-1 expressingex-vivocultured tumor infiltrating lymphocytes confers tumor reactivity in cervical cancer: Possible implication for adoptive cell therapy (2020) (0)
- Human PBMC-transferred murine MHC class I/II-deficient NOG mice enable long-term evaluation of human immune responses (2017) (0)
- [Cellular immunotherapy of cancer]. (2003) (0)
- PD-1/PD-L1 immune check points blockade to attenuate growth of metastatic colon cancer in the CBP/β-catenin inhibited liver. (2019) (0)
- Tumor immunity and immunosurveillance, session 1 (WS-093a) Chairpersons: Kazuyoshi Takeda, Bruce Robinson (2010) (0)
- Blockade for CD155-TIGIT interaction elicits anti-melanoma T cell responses in vitro and in vivo (2016) (0)
This paper list is powered by the following services:
What Schools Are Affiliated With Yutaka Kawakami?
Yutaka Kawakami is affiliated with the following schools:
